Monday Plan: Hold the Book as Iran Escalation Tests Risk Appetite
TSMC AI Demand Confirmation Supports NVDA Thesis
The book holds unchanged at LLY 27%, META 23%, JPM 20%, NVDA 17%, AMZN 13% into Monday's session. US-Iran military escalation across nine consecutive nights — Brent breaching $90 on Hormuz risk — introduces an elevated geopolitical risk premium at the open, but no holding thesis breaks. TSMC's explicit announcement of accelerated Arizona AI chip factory buildout is a direct demand confirmation for the Blackwell compute cycle. Caution is expressed through existing sizing and name selection, not defensive rotation.
Prior plan graded: LLY anchored correctly at 27% as the sole Friday winner at +0.85%, validating the conviction sizing. META at -2.79% and NVDA at -2.21% were the primary detractors; the book returned -1.05% versus SPY's -0.99%, a 6bps shortfall consistent with high-growth beta on a broad risk-off Friday. Thesis integrity holds across all five names.
Since Last Session
Friday, July 17 delivered a broad risk-off session with the book returning -1.05% against SPY's -0.99%. LLY was the sole positive contributor at +0.85%, with all four other names in the red. META led the drawdown at -2.79%, followed by NVDA at -2.21%, AMZN at -1.06%, and JPM at -0.60%. The weighted underperformance of 6bps reflects the high-growth tech and AI tilt in a session where the tape sold off broadly.
Plan for Monday
Monday opens into a materially elevated geopolitical risk environment. The US has struck Iran for nine consecutive nights with American casualties rising; Brent crude has breached $90 on Strait of Hormuz risk; and NATO's military chief has warned publicly that a Russian move on the Baltic states would carry severe consequences. The VIX at 18.77 — elevated from the 16.73 print in the prior plan — signals that the options market is pricing a more uncertain open than the book has navigated in recent sessions.
The plan is to hold the book unchanged. No holding thesis has broken over the weekend, and the TSMC Arizona acceleration announcement provides an explicit AI infrastructure demand confirmation that is directly relevant to the NVDA position and the broader AI cycle thesis.
Position-by-position intent going into Monday:
- LLY at 27%: The sole Friday winner and confirmed anchor. Monday's geopolitical risk-off is not a GLP-1 demand event. Healthcare earnings durability holds regardless of Hormuz pricing. Hold and monitor for any CMS or biosimilar catalyst.
- META at 23%: Friday's -2.79% is now priced. The Monday question is whether the Iran-driven risk-off extends the tech sell-off into ad-dependent names or whether META's AI infrastructure narrative attracts buyers on the pullback. The hold is conditional: a gap-down that recovers an intraday bid within the first 30 minutes reinforces the thesis; a sustained break below the 20-day average on volume would prompt a trim toward 18-19%.
- JPM at 20%: Capital markets activity is not rate-path-dependent in the near term. Iran escalation introduces credit-spread monitoring but JPM's revenue mix favors transaction volume over pure NIM. Hold.
- NVDA at 17%: TSMC's announcement is the pivotal read-through for this position. TSMC does not accelerate US fab capacity for demand that does not exist — this is explicit AI infrastructure capex confirmation. The 60-day at -2.95% crosses the monitoring threshold, but the compound exit condition requires a hyperscaler order revision, which the TSMC signal argues directly against. Hold.
- AMZN at 13%: 60-day constraint active at -2.69%. AWS thesis intact. Q2 earnings remain the re-rating catalyst for a return to 15%. Hold.
What must confirm at the open: SPY should establish an intraday recovery bid within the first session rather than establishing a new downtrend off the Iran gap. If Monday sees XLE decouple sharply to the upside while the rest of the tape continues to sell — signaling a genuine Hormuz supply-disruption premium being priced — the plan would require intraday reassessment of whether META and NVDA can hold in that rotation environment.
Positioning
| Symbol | Weight | Role |
|---|---|---|
| LLY | 27% | Healthcare secular-growth anchor; only Friday winner; 60-day +9.44% leads universe |
| META | 23% | AI infrastructure momentum; first-party data moat; 20-day +6.73% |
| JPM | 20% | Financials leadership; 60-day +7.61%; capital markets AI-trading thesis |
| NVDA | 17% | Blackwell cycle; TSMC demand confirmation; compound exit condition inactive |
| AMZN | 13% | AWS cloud migration; 60-day constraint active; institutional backing |
| Cash | 0% | Fully invested |
The book enters Monday at full deployment. The absence of defensive rotation — no XLE, no GLD, no TLT — reflects the standing rule: caution is expressed through which growth names are held and how they are sized, not through a defensive overlay. Energy's outperformance (XLE 20-day +5.38%) is a data point, not a mandate; the Iran trade would require an explicit supply-disruption confirmation before entering the book as a conviction position rather than a geopolitical hedge.
Institutional Signals
Bridgewater holds both AMZN (4.1%) and NVDA (3.7%), providing dual institutional endorsement for the two positions where momentum is currently negative but thesis remains intact. Pershing Square holds AMZN at 17.4% — its second-largest position — reflecting long-duration conviction in the AWS cloud transition that aligns with this book's 13% allocation. Scion's 13.5% NVDA weight alongside Bridgewater's 3.7% represents a contrarian institutional endorsement precisely when the 60-day momentum signal is below the monitoring threshold; Burry's concentration in NVDA as his second-largest holding is noted as a structural signal, not a timing one. Pershing Square's 15.3% MSFT position is a relevant comparable as an AI infrastructure anchor play, but MSFT's 60-day at -2.66% and weaker sector positioning relative to META and NVDA argue against substitution. Berkshire's non-tech concentration (AAPL, AXP, KO) and the implication of a large cash buffer confirm that the broader market's consensus leadership is narrow — which is precisely the environment where single-name secular-growth positioning outperforms broad index exposure.
What Could Break It
- Iran escalation broadens to Hormuz closure or direct US-Iran naval engagement: A genuine supply disruption would reprice risk assets broadly, accelerate XLE/XOM outperformance, and likely compress META and NVDA. The plan would require immediate assessment of whether to enter XLE at the expense of 3-5% from META or NVDA.
- META sustained close below the 20-day average on volume: Would signal that Friday's -2.79% was not a mean-reversion entry but the beginning of a trend change. A confirmed breakdown would prompt a trim from 23% to 18-19%.
- NVDA hyperscaler order revision: Any major cloud provider publicly revising AI capex guidance downward would activate the compound exit condition alongside the current 60-day below -2%. A credible revision would trigger a trim to 10-12% or full exit depending on severity and breadth.
- LLY adverse CMS ruling or credible biosimilar IND filing: The primary anchor thesis depends on GLP-1 coverage durability and the absence of near-term tirzepatide biosimilar competition. Either event would require immediate reassessment of the 27% weight.
- VIX sustained above 25: Would signal a volatility regime shift and compress risk tolerance for high-growth positions across the book, triggering a broad sizing review.